Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1964 2
1965 2
1966 1
1967 1
1968 1
1969 2
1970 3
1972 3
1973 1
1975 1
1976 1
1977 2
1979 1
1980 2
1981 6
1982 4
1983 9
1984 13
1985 4
1986 8
1987 9
1988 7
1989 15
1990 27
1991 9
1992 18
1993 22
1994 21
1995 20
1996 24
1997 27
1998 30
1999 31
2000 25
2001 25
2002 18
2003 35
2004 28
2005 37
2006 35
2007 27
2008 30
2009 39
2010 32
2011 56
2012 37
2013 49
2014 64
2015 44
2016 53
2017 71
2018 59
2019 83
2020 101
2021 94
2022 75
2023 85
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

1,418 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. Among authors: nishio m. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Development and web deployment of prediction model for pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension using machine learning.
Matsunaga T, Kono A, Nishio M, Yoshii T, Matsuo H, Takahashi M, Takahashi T, Taniguchi Y, Tanaka H, Hirata K, Murakami T. Matsunaga T, et al. Among authors: nishio m. PLoS One. 2024 Apr 5;19(4):e0300716. doi: 10.1371/journal.pone.0300716. eCollection 2024. PLoS One. 2024. PMID: 38578764 Free PMC article.
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer.
Yamamoto N, Satouchi M, Doi T, Fujiwara Y, Yanagitani N, Kawa Y, Yoh K, Leopold L, Munteanu M, Sawada T, Han S, Noguchi K, Nishio M. Yamamoto N, et al. Among authors: nishio m. Invest New Drugs. 2024 Mar 26. doi: 10.1007/s10637-024-01422-6. Online ahead of print. Invest New Drugs. 2024. PMID: 38530565
Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM.
Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Nishio M, Kato T, Takahashi T, Ebi H, Aono M, Yamamoto N, Ohe Y, Nakagawa K. Watanabe S, et al. Among authors: nishio m. ESMO Open. 2024 Apr;9(4):102975. doi: 10.1016/j.esmoop.2024.102975. Epub 2024 Mar 22. ESMO Open. 2024. PMID: 38520847 Free PMC article. Clinical Trial.
1,418 results